Home / Oil and Gas / Brain Ischemia Global Clinical Trials Review, H1, 2015

Brain Ischemia Global Clinical Trials Review, H1, 2015

Published: Mar 2015 | No Of Pages: 74 | Published By: GlobalData

Brain Ischemia Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Brain Ischemia Global Clinical Trials Review, H1, 2015" provides data on the Brain Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Brain Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Brain Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Brain Ischemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Brain Ischemia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Brain Ischemia to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Brain Ischemia 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Brain Ischemia Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
C. H. Boehringer Sohn AG & Co. KG 32
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 32
F. Hoffmann-La Roche Ltd. 33
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33
Bayer AG 34
Clinical Trial Overview of Bayer AG 34
Prolong Pharmaceuticals 35
Clinical Trial Overview of Prolong Pharmaceuticals 35
NoNO, Inc. 36
Clinical Trial Overview of NoNO, Inc. 36
Mitsubishi Chemical Holdings Corporation 37
Clinical Trial Overview of Mitsubishi Chemical Holdings Corporation 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Edge Therapeutics, Inc. 39
Clinical Trial Overview of Edge Therapeutics, Inc. 39
D-Pharm Ltd. 40
Clinical Trial Overview of D-Pharm Ltd. 40
Clinical Trial Overview of Top Institutes / Government 41
Asan Medical Center 41
Clinical Trial Overview of Asan Medical Center 41
China Medical University Hospital 42
Clinical Trial Overview of China Medical University Hospital 42
Gachon University Gil Hospital 43
Clinical Trial Overview of Gachon University Gil Hospital 43
UMC Utrecht Holding BV 44
Clinical Trial Overview of UMC Utrecht Holding BV 44
University of Southern California 45
Clinical Trial Overview of University of Southern California 45
Academic Medical Center 46
Clinical Trial Overview of Academic Medical Center 46
Auckland City Hospital 47
Clinical Trial Overview of Auckland City Hospital 47
Centre hospitalier de l'Universite de Montreal 48
Clinical Trial Overview of Centre hospitalier de l'Universite de Montreal 48
Centre Hospitalier Universitaire de Poitiers 49
Clinical Trial Overview of Centre Hospitalier Universitaire de Poitiers 49
Centre Hospitalier Universitaire de Saint Etienne 50
Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne 50
Five Key Clinical Profiles 51
Appendix 72
Abbreviations 72
Definitions 72
Research Methodology 73
Secondary Research 73
About GlobalData 74
Contact Us 74
Disclaimer 74
Source 74

List of Tables
Brain Ischemia Therapeutics, Global, Clinical Trials by Region, 2015* 7
Brain Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Brain Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Brain Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Brain Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Brain Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Brain Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Brain Ischemia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Brain Ischemia to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Brain Ischemia Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Brain Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Brain Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Brain Ischemia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Brain Ischemia Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Brain Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Brain Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Brain Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Brain Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Brain Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 32
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 33
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 34
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Prolong Pharmaceuticals, 2015* 35
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by NoNO, Inc., 2015* 36
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Chemical Holdings Corporation, 2015* 37
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 38
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Edge Therapeutics, Inc., 2015* 39
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by D-Pharm Ltd., 2015* 40
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 41
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by China Medical University Hospital, 2015* 42
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gachon University Gil Hospital, 2015* 43
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2015* 44
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern California, 2015* 45
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 46
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Auckland City Hospital, 2015* 47
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre hospitalier de l'Universite de Montreal, 2015* 48
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Poitiers, 2015* 49
Brain Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2015* 50

List of Figures
Brain Ischemia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Brain Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Brain Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Brain Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Brain Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Brain Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Brain Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Brain Ischemia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Brain Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Brain Ischemia to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Brain Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Brain Ischemia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Brain Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Brain Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Brain Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Brain Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Brain Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Brain Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Brain Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Brain Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 73

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +